Introduction
============

Ventilatory strategies in pediatric intensive care are frequently based on strategies developed in adult or neonatal intensive care units \[[@B1]\]. Recently two new ventilatory techniques with almost identical names have been developed for adults: BiPAP^®^ and BIPAP. BiPAP^®^ is a trade name derived from \'bi-level positive airway pressure\'. BiPAP^®^ delivers, by mask, two levels of pressure in response to patient flow. It is intended to support ventilation in a nonin-vasive way in spontaneously but insufficiently breathing patients in the home care environment \[[@B2], [@B3]\]. In contrast, BIPAP (biphasic positive airway pressure) is a mode of ventilation developed for full ventilatory support in intensive care settings with the use of an endotracheal tube.

This paper is about BIPAP; in US literature, BIPAP is also known as PeV+. BIPAP uses cycling variations between two continuous positive airway pressure levels, allowing spontaneous breathing during every ventilatory phase \[[@B4], [@B5], [@B6]\]. In adults this mode of ventilation results in effective ventilation at lower inspiratory peak pressure levels, in less ventilation-perfusion mismatch, and in less dead-space ventilation \[[@B7]\]. Because of the ability to breathe spontaneously during every ventilatory phase, ventilation is being accepted with a decreased need for sedatives \[[@B8], [@B9]\]. BIPAP can be used during the entire period of artificial ventilation, including the weaning process, by prolonging the periods of low pressure level \[[@B5], [@B10], [@B11]\].

Better acceptance of ventilation, resulting in a decreased need for sedatives, would be advantageous in the ventilation of children. Increased work of breathing might be a problem in children when BIPAP is used in the weaning phase because of a prolongation of periods of low pressure levels.

No studies with BIPAP have been performed in children until now. We performed a study to determine whether BIPAP is an effective, safe and easy to use mode of ventilation in children, resulting in a decreased need for sedatives.

Methods
=======

Patients and protocols
----------------------

We had intended to compare BIPAP with pressure support ventilation \[assisted spontaneous breathing (ASB)\] with the use of Evita 4 (Dräger, Lübeck, Germany) in 25 patients each. However, soon after the introduction of Evita 4 on the ward, physicians and nurses preferred the use of BIPAP over ASB, and inclusion of patients stopped. We therefore studied a total of 18 patients admitted to the Pediatric Intensive Care Unit of the University Hospital of Groningen. Exclusion criteria were: weight less than 3000 g, cyanotic heart disease or neuromuscular disease. Randomization was performed by the coin method and took place when paralysis, used for intubation, had been resolved. Initial ventilator settings depended on age and the reason for respiratory failure, and were adjusted according to thoracic excursions and measured tidal volume. Adjustments were made afterwards aiming at a *p*CO~2~ of 4-5 kPa and a *p*O~2~of 8-11 kPa.

Sedatives were given in accordance with the Comfort scale (Table [1](#T1){ref-type="table"}), which is a nonintrusive measure for assessing distress in pediatric intensive care patients, with high inter-rater agreement and high internal consistency \[[@B12]\]. Good sedation is obtained when the total score is between 17 and 26. The Comfort scale was obtained by trained nurses at 2 h intervals for the first 24 h after intubation, and afterwards at 6 h intervals. Lorazepam (0.4 mg/kg in four divided doses) was used as sedative. To keep the Comfort scale score between 17 and 26, the lorazepam dose was adjusted as needed to a maximum of 0.6 mg/kg in six divided doses. If more sedatives were needed, morphine was added at a loading dose of 100 μg/kg and a maintenance dose of 10-20 μg/kg per hour. Randomized mode failure was recorded if, despite optimal ventilatory settings and the optimal use of sedatives, the patient could not be ventilated adequately. The patient was then transferred to the other study ventilatory mode; if neither succeeded, the study was stopped.

The recorded patient characteristics were age, weight, gender, diagnosis and paediatric risk of mortality (PRISM) score. The recorded ventilatory parameters were ventila-tory mode, duration of ventilation, and complications of ventilation (atelectasis or accidental extubation). Registered parameters for adequacy of sedation were the Comfort scale and the number and dosage of sedatives.

The following endpoints of the study were considered: number of patients transferred to the alternative ventilatory mode because of inadequate ventilation or high Comfort scale despite maximal sedative use according to study protocol, complications of ventilation, and number and dosage of sedatives administered.

Statistical analysis
--------------------

Continuous and ordinal variables were checked for normal distribution with one sample Kolmogorov-Smirnov test. Age and weight were not normally distributed and were analysed for statistical significant differences with the two-sample Kolmogorov-Smirnov test for small numbers. PRISM score, duration of ventilation, lorazepam dosage and morphine dosage were normally distributed and were analysed for statistically significant differences with the independent-samples *t*-test. Fisher\'s exact test was used to analyse whether statistically significant numbers of patients experienced randomized mode failure or needed the addition of morphine as a sedative.

Results
=======

Eighteen patients were included. Reasons for respiratory failure were diverse. In the BIPAP group, five patients were ventilated postoperatively, four patients were ventilated because of infection, one patient was ventilated because of pulmonary hypertension accompanying cardiac disease, and one patient was ventilated because of obstruction of the upper airway. In the ASB group, two patients were ventilated postoperatively, three patients were ventilated because of infection, one patient was ventilated because of pulmonary hypertension accompanying cardiac disease, and one patient was ventilated because of obstruction of the upper airway. Patient characteristics are described in Table [2](#T2){ref-type="table"}; ventilatory parameters and the use of sedatives are shown in Table [3](#T3){ref-type="table"}.

No differences in patient characteristics, duration of ventilation, complications of ventilation or need for sedatives were noted.

After randomization, we intended to treat eleven patients with BIPAP, which succeeded in ten patients. The one patient that could not be ventilated with BIPAP was transferred to ASB, which did not succeed either. Afterwards the infant was successfully ventilated with Babylog 8000 (Dräger). Eight of the eleven patients needed the addition of morphine for adequate sedation.

We had intended to treat seven patients with ASB, which succeeded in three patients. The four patients that could not be ventilated with ASB were transferred to BIPAP, which succeeded in all of them. These four patients needed the addition of morphine for adequate sedation during ASB, but during BIPAP no sedatives were added.

Discussion
==========

BIPAP is a new mode of artificial ventilation that has been used successfully in adult patients. In adults this ventila-tory mode results in a shorter duration of ventilation, a decreased need for sedatives and fewer complications in comparison with pressure controlled or pressure supported ventilation \[[@B4]\]. We demonstrated in the present study that BIPAP can be used safely and effectively in infants and children. We found no differences in the duration of ventilation, in the incidence of complications or in the use of sedatives in comparison with ASB. However, ventilation with ASB resulted in a significantly greater number of randomized mode failures than ventilation with BIPAP, and transfer to BIPAP resulted in successful ventilation without the need for added sedatives in all patients. We therefore believe that BIPAP might be advantageous over ASB.

However, from this study we cannot conclude that BIPAP is a better mode of ventilation for infants and children with a decreased need of sedatives than other modes of ventilation: the number of patients included was too small. We had planned to include more patients, but soon after introduction of Evita 4 on the ward, physicians and nurses preferred to use BIPAP over ASB and the patients\' inclusion in the study stopped. The reasons for this preference of people on the ward for BIPAP could be one or more of the following: a preference for the newest mode of ventilation, the increased rate of randomized mode failure in the ASB group, or the possibility of using BIPAP during the entire period of artificial ventilation without the necessity to switch between ventilatory modes when patients are paralysed or when weaning is initiated. To exclude those possible biases one would have to to perform a blinded study.

We conclude that BIPAP is an effective, safe and easy to use mode of ventilation in infants and children. Its use for ventilation of infants and children during the entire period of artificial ventilation makes this mode of ventilation suitable for use in training hospitals.

Abbreviations
=============

ASB = assisted spontaneous breathing; BIPAP = biphasic positive airway pressure; PRISM, paediatric risk of mortality.

Figures and Tables
==================

###### 

Comfort scale \[[@B12]\]

                         Score                                                                                           
  ---------------------- -------------------- ------------------------- ----------------------- ------------------------ ---------------------
  Alertness              Deeply asleep        Lightly asleep            Drowsy                  Fully awake and alert    Hyper alert
  Calmness/agitation     Calm                 Slightly anxious          Anxious                 Very anxious             Panicky
  Respiratory response   No coughing and      Spontaneous               Occasional cough        Actively breathes        Fights ventilator,
                         no spontaneous       respiration with little   or resistance to        against ventilator or    coughing or choking
                         respiration          or no response to         ventilator              coughs regularly         
                                              ventilation                                                                
  Physical movement      No movement          Occasional, slight        Frequent, slight        Vigorous movement        Vigorous movements
                                              movement                  movements               limited to extremities   including torso and
                                                                                                                         head
  Mean arterial          Blood pressure       Blood pressure            Infrequent elevations   Frequent elevations of   Sustained elevation
  blood pressure         below baseline       consistently at           of 15% or more          15% or more above        of 15% or more
                                              baseline                  (1-3 during             baseline (more than 3    
                                                                        observation period)     during observation       
                                                                                                period)                  
  Heart rate             Heart rate below     Heart rate                Infrequent elevations   Frequent elevations of   Sustained elevation
                         baseline             consistently at           of 15% or more          15% or more above        of 15% or more
                                              baseline                  above baseline (1-3     baseline (more than 3    
                                                                        during observation      during observation       
                                                                        period)                 period)                  
  Muscle tone            Muscle totally       Reduced muscle tone       Normal muscle tone      Increased muscle tone    Extreme muscle
                         relaxed, no muscle                                                     and flexion of fingers   rigidity
                         tone                                                                   and toes                 
  Facial tension         Facial muscles       Facial muscle tone        Tension evident in      Tension evident          Facial muscles
                         totally relaxed      normal, no facial         some facial muscles     throughout facial        contorted and
                                              muscle tension evident    muscles                 grimacing                

###### 

Patient characteristics

  Characteristic           BIPAP (*n* = 11)             ASB (*n* = 7)                Significance
  ------------------------ ---------------------------- ---------------------------- --------------
  Age^\*^                  4 mo (6 wk to 21 months)     4 mo (4 weeks to 10 years)   *P* = 0.88
  Weight^\*^               5125 g (3300 g to 13.5 kg)   5150 g (3925 g to 27 kg)     *P* = 0.88
  Numbers of each gender   5 male, 6 female             5 male, 2 female             
  PRISM score^\*^          2 (0-17)                     6 (0-17)                     *P* = 0.81

^\*^Median and range.

###### 

Ventilatory parameters and use of sedatives

  Parameter                                      BIPAP (*n* = 11)   ASB (*n* = 7)   Significance
  ---------------------------------------------- ------------------ --------------- --------------
  Randomized mode failure (no.)                  1^†^               4               *P* = 0.047
  Duration of ventilation (days)^\*^             9.8 ± 9.2          6.4 ± 5.8       *P* = 0.27
  Atelectasis (no.)                              5                  3               *P* = 1.0
  Accidental extubation (no.)                    1                  0               *P* = 1.0
  Sedatives                                                                         
   Lorazepam (all), dosage (mg/kg per day)^\*^   0.43 ± 0.12)       0.46 ± 0.16     *P* = 0.76
   Morphine added(no.)                           8^‡^               4               *P* = 0.63
    Dosage (μg/kg per h)^\*^                     9.34 ± 7.32        6.61 ± 7.10     *P* = 0.45

^\*^Data are shown as means ± SD. ^†^In this patient, after transfer, ASB did not succeed either. The infant was ventilated with Babylog 8000. ^‡^In two patients midazolam was also added, at 100-200 μg/kg per h.
